Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Nov 6;9(3):306–316. doi: 10.1007/s12975-017-0577-8

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2017, corrected publication November/2017

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PMC Copyright notice

Fig. 3 — Effects of post-ischemia treatment with PGZ in OVX/GFP^+BM rats. PGZ or vehicle (VC) was administered immediately after MCAO induction on day 0 and once a day for 14 consecutive days. The infarct volume (a) was recorded in OVX/GFP^+BM rats treated with PGZ or VC (each group n = 12). The neurological score (b) was assessed as described in Materials and Methods. Each bar represents the mean ± SD *p < 0.05 vs. VC by ANOVA followed by Scheffe’s test. Representative immunohistochemistry findings for PPARγ, Musashi-1, and GFP (d) in the SVZ after MCAO-R